Acute and chronic antiepileptic drug effect on the T complex interhemispheric latency difference.

TitleAcute and chronic antiepileptic drug effect on the T complex interhemispheric latency difference.
Publication TypeJournal Article
Year of Publication1978
AuthorsWolpaw, J, Penry, JK
JournalEpilepsia
Volume19
Pagination99–107
Date Published02/1978
ISSN0013-9580
KeywordsAntiepileptic drug effects, Auditory evoked response, Hemispheric difference, T complex
Abstract

Antiepileptic drugs may significantly affect brain function in the absence of overt toxicity or excessive serum drug levels. A clinically practical monitor of such effects would be of considerable value in clinical research and practice.

Auditory evoked responses were recorded from patients before and after initiation of antiepileptic drug therapy and from patients on therapy for at least 1 year. T complexes were isolated (Wolpaw and Penry, 1975), and Ta peak ipsilateral versus contralateral latency differences were determined.

In 13 patients beginning phenobarbital, more than half the postdrug determinations were significantly increased over the patients' predrug control values in the first 30 days and thereafter, and grossly abnormal values were frequent. In 10 patients beginning phenytoin, latency differences were similarly increased, although grossly abnormal values were less common. In 2 patients beginning clonazepam, 14 of 15 postdrug determinations were significantly increased, and five were grossly abnormal. In no patients were serum drug levels above the therapeutic ranges. In 40 patients chronically treated with phenobarbital or primidone, phenytoin, or a combination of phenytoin and phenobarbital or primidone, abnormal latency differences were obtained in 33, 36, and 29% of the determinations, respectively.

The Ta peak ipsilateral versus contralateral latency difference is an internally controlled correlate of higher level specific sensory function which is sensitive to acute and chronic therapy with phenobarbital, phenytoin, or clonazepam in therapeutic dosages. With further investigation, it may be of clinical use.

URLhttp://www.ncbi.nlm.nih.gov/pubmed/624272
DOI10.1111/j.1528-1157.1978.tb05017.x

You are here